Glucagon-like peptide-1 receptor agonist and amylin analogue combinations Amylin is co-secreted with insulin from the pancreas and contributes to postprandial satiety regulation, delays gastric emptying and inhibits glucagon secretion
With the professional experience and medical expertise of our board-certified physician, we will guide you towards a healthy lifestyle in a supportive and comfortable environment
The duration of treatment depends on your individual needs and weight loss goals
As a result, users often experience gradual weight loss
Rare, but serious side effects include: Pancreatitis (inflammation of the pancreas) Diabetic retinopathy complications Hypoglycemia (low blood sugar) Acute kidney injury Serious allergic reactions Acute gallbladder disease Thyroid cancer Although rare, adverse events like severe gastroparesis (stomach paralysis) and bowel obstruction are possible when taking GLP-1 medications, whether for diabetes or weight loss
Kumar agrees, adding, "It's important to understand that your body already produces GLP-1 naturally